{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:59:46Z","timestamp":1791230386342,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":577,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1111\/j.1469-0691.2012.03879.x","type":"journal-article","created":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T13:00:11Z","timestamp":1333458011000},"page":"474-479","source":"Crossref","is-referenced-by-count":229,"title":["Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients"],"prefix":"10.1016","volume":"19","author":[{"given":"C.","family":"Gudiol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bodro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tubau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gonz\u00e1lez-Barca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cisnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Domingo-Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Carratal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2012.03879.x_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationship between circulating leukocytes and infection in patients with acute leukaemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0002-9343(77)90876-2","article-title":"Bacteremia and fungemia complicating neoplastic disease","volume":"62","author":"Singer","year":"1977","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1086\/598620","article-title":"Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria","volume":"29","author":"Zinner","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2012.03879.x_bib5","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/383048","article-title":"Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens","volume":"39","author":"Ramphal","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/317460","article-title":"Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer","volume":"31","author":"Marron","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib8","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/clinids\/20.5.1169","article-title":"Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer","volume":"20","author":"Carratal\u00e0","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib9","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/clinids\/14.6.1201","article-title":"Septicemia and shock syndrome due to viridans streptococci: a case\u2013control study of predisposing factors","volume":"14","author":"Elting","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/345435","article-title":"Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy","volume":"36","author":"Cordonnier","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01695660","article-title":"Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution","volume":"15","author":"Gonz\u00e1lez-Barca","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib12","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement","author":"Clinical and Laboratory Standards Institute (Formely NCCLS)","year":"2011"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1099\/jmm.0.46747-0","article-title":"The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"55","author":"Falagas","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib14","series-title":"Manual of clinical microbiology","year":"2007"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib15","series-title":"Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib16","series-title":"Performance standards for antimicrobial disk susceptibility test","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkl425","article-title":"Effect of quionolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis","volume":"59","author":"Gafter-Gvili","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib18","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/AAC.40.2.503","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis","volume":"40","author":"Carratal\u00e0","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/clinids\/20.3.557","article-title":"Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin","volume":"20","author":"Carratal\u00e0","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/AAC.38.4.681","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center","volume":"38","author":"Kern","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib23","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.40.19983-en","article-title":"Trends in yearly prevalence of third-generation and fluoroquionolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010","volume":"16","author":"Asensio","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/JCM.42.3.1089-1094.2004","article-title":"Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients","volume":"42","author":"Rodr\u00edguez-Ba\u00f1o","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib25","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3201\/eid1209.060397","article-title":"Fluoroquinolones and risk for methicillin-resistant Staphyloccocus aureus, Canada","volume":"12","author":"LeBlanc","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib26","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/archinte.1983.00350010034007","article-title":"Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy","volume":"143","author":"Winston","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/clinids\/18.1.25","article-title":"Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors","volume":"18","author":"Bochud","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bmt.1705677","article-title":"Epidemiology of bacteremia and factors associated with multi-drug-resistant Gram-negative bacteremia in hematopoietic stem cell transplant recipients","volume":"39","author":"Oliveira","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge","volume":"43","author":"Rodr\u00edguez-Ba\u00f1o","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dkq494","article-title":"Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes","volume":"66","author":"Gudiol","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.diagmicrobio.2009.02.008","article-title":"Factors associated with mortality in bacteremic patients with hematologic malignancies","volume":"64","author":"Tumbarello","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1086\/502158","article-title":"Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case\u2013control study","volume":"24","author":"Wisplinghoff","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused antibiotic resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with haematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/AAC.39.2.445","volume":"39","author":"Cometta","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJM199404283301717","article-title":"Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia","volume":"330","author":"Cometta","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000007223","article-title":"Susceptibility surveillance among gram-negative bacilli at a cancer center","volume":"45","author":"Jacobson","year":"1999","journal-title":"Chemotherapy"},{"key":"10.1111\/j.1469-0691.2012.03879.x_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1179\/joc.1998.10.4.320","article-title":"Bacteraemia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study","volume":"10","author":"Krcm\u00e9ry","year":"1998","journal-title":"J Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14605218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14605218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T13:49:41Z","timestamp":1561556981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14605218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1198743X14605218"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03879.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}